Form 4: Semler Scientific Director Eric Semler Acquires Stock Options

Director Eric Semler acquired stock options for Semler Scientific, Inc. on January 6, 2025.

Summary

• On January 6, 2025, Eric Semler, a director of Semler Scientific, Inc., acquired stock options to purchase shares of the company's common stock.
• The first option grants the right to buy 8,000 shares at $58.94, vesting monthly over one year and expiring on January 6, 2035.
• The second option grants the right to buy 150,000 shares at $58.94, vesting monthly over two years and expiring on January 29, 2027.
• Following the transaction, Semler directly owns options for 158,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which can be seen as a positive sign of aligning management interests, but doesn't inherently indicate strong positive or negative sentiment.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the technology and healthcare industries, often used to align management's interests with those of shareholders.
• Vesting schedules, such as the monthly vesting described in the document, are standard practice to incentivize long-term commitment.
• Companies like Medtronic and Boston Scientific also use stock options as part of their compensation packages.

Stakeholder Impact

• The granting of stock options can potentially impact shareholders by diluting the value of existing shares if the options are exercised.

Key Dates